Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Pravastatin in Dysbetalipoproteinemia
NCT00214604Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2005
- Primary completion
- Feb 2007
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of rosuvastatin in dysbetalipoproteinemia (DBL), sponsored by AstraZeneca. Started Feb 2005; status: completed.
02
Drugs
rosuvastatin
03
Conditions
dysbetalipoproteinemia (DBL)
Beyond the preview
Go deeper on NCT00214604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00214604.